Muir-Torre syndrome caused by partial duplication of MSH2 gene by Alu-mediated nonhomologous recombination

British Journal of Dermatology

Volumn 158, Issue 1, 2008, Pages 150-156

  Yanaba, K ^a   Nakagawa, H ^a   Takeda, Y ^b   Koyama, N ^c   Sugano, K ^b,c  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY HOSPITAL   (Japan)

^c TOCHIGI CANCER CENTER   (Japan)

Author keywords

Genomic duplication; Hereditary nonpolyposis colorectal cancer; Microsatellite instability; Muir Torre syndrome; Sebaceous carcinoma

Indexed keywords

GENOMIC DNA; PROTEIN MSH2;

ADULT; ALU SEQUENCE; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE REPORT; CLINICAL FEATURE; COLON ADENOCARCINOMA; DIGESTIVE SYSTEM CANCER; EXON; GENE DUPLICATION; GENE MUTATION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUIR TORRE SYNDROME; NECK TUMOR; NUCLEOTIDE REPEAT; PEDIGREE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEBACEOUS CARCINOMA; SEQUENCE HOMOLOGY; STOP CODON;

ADENOCARCINOMA; ADENOCARCINOMA, SEBACEOUS; BASE SEQUENCE; COLONIC NEOPLASMS; GENE DUPLICATION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTS HOMOLOG 2 PROTEIN; NEOPLASTIC SYNDROMES, HEREDITARY; PEDIGREE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEBACEOUS GLAND NEOPLASMS;

EID: 36849084499     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08233.x     Document Type: Article

References (25)

1. Cohen PR, Kohn SR, Davis DA et al. Muir-Torre syndrome. Dermatol Clin 1995 13 : 79 89.
2. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995 33 : 90 104.
3. Lynch HT, Smyrk TC, Watson P et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993 104 : 1535 49.
4. Lynch HT, Fusaro RM, Roberts L et al. Muir-Torre syndrome in several members of a family with a variant of the cancer family syndrome. Br J Dermatol 1985 113 : 295 301.
5. Vasen HF, Watson P, Mecklin JP et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999 116 : 1453 6.
6. Umar A, Boland CR, Terdiman JP et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004 96 : 261 8.
7. Nomura S, Sugano K, Kashiwabara H et al. Enhanced detection of deleterious and other germline mutations of hMSH2 and hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds. Biochem Biophys Res Commun 2000 271 : 120 9.
8. Sumitsuji I, Sugano K, Matsui T et al. Frequent genomic disorganisation of MLH1 in hereditary non-polyposis colorectal cancer (HNPCC) screened by RT-PCR on puromycin treated samples. J Med Genet 2003 40 : e30.
9. Schouten JP, McElgunn CJ, Waaijer R et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002 30 : e57.
10. Gille JJ, Hogervorst FB, Pals G et al. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 2002 87 : 892 7.
11. Kruse R, Rutten A, Schweiger N et al. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. J Invest Dermatol 2003 120 : 858 64.
12. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 1991 90 : 606 13.
13. Cohen PR. Sebaceous carcinomas of the ocular adnexa and the Muir-Torre syndrome. J Am Acad Dermatol 1992 27 : 279 80.
14. Gylling A, Abdel-Rahman WM, Juhola M et al. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study. Gut 2007 56 : 926 33.
15. Vasen HF, Mecklin JP, Khan PM et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991 34 : 424 5.
16. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993 260 : 816 19.
17. Honchel R, Halling KC, Schaid DJ et al. Microsatellite instability in Muir-Torre syndrome. Cancer Res 1994 54 : 1159 63.
18. Entius MM, Keller JJ, Drillenburg P et al. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res 2000 6 : 1784 9.
19. Kruse R, Rutten A, Hosseiny-Malayeri HR et al. 'Second hit' in sebaceous tumors from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation. J Invest Dermatol 2001 116 : 463 5.
20. Machin P, Catasus L, Pons C et al. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol 2002 29 : 415 20.
21. Ponti G, Losi L, Di Gregorio C et al. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer 2005 103 : 1018 25.
22. Marcus VA, Madlensky L, Gryfe R et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999 23 : 1248 55.
23. Kruse R, Rutten A, Lamberti C et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet 1998 63 : 63 70.
24. Mangold E, Pagenstecher C, Leister M et al. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet 2004 41 : 567 72.
25. Akhtar S, Oza KK, Khan SA et al. Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol 1999 41 : 681 6.